Group 1 - The company has changed its English name from "Genor Biopharma Holdings Limited" to "Edding Genor Group Holdings Limited" and its Chinese name from "嘉和生物药业(开曼)控股有限公司" to "亿腾嘉和医药集团有限公司," effective from December 30, 2025 [1] - The change in company name has been approved by shareholders at a special meeting and certified by the Registrar of Companies in the Cayman Islands [1] - The new names have been registered in Hong Kong under the Companies Ordinance, confirming the new English and Chinese names [1] Group 2 - The company's stock trading name on the Hong Kong Stock Exchange will change from "GENOR" to "EDDING GENOR," and the Chinese stock name will change from "嘉和生物" to "亿腾嘉和," effective from February 6, 2026 [2] - The company's stock code on the Hong Kong Stock Exchange will remain "6998" despite the name changes [2] - The name changes aim to align with the expanded business of the group post-merger and better reflect the relationship with the controlling shareholder [2]
嘉和生物(06998)拟更改股份简称为“亿腾嘉和”